Piper Sandler analyst David Amsellem maintains Amphastar Pharma (NASDAQ:AMPH) with a Neutral and

Wells Fargo analyst Benjamin Burnett maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight

Amphastar Pharmaceuticals, Inc. (AMPH) Q2 2026 Earnings Call Transcript

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the

Amphastar Pharmaceuticals NASDAQ: AMPH reported second-quarter 2026 revenue growth, supported by rec

Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.91 per share which beat the analyst

Net revenues of $183.9 million for the three months ended June 30, 2026 GAAP net income of $30.3 mil

RANCHO CUCAMONGA, Calif., July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMP

Trump sets a 2-year ultimatum for generic drugmakers to reshore U.S. production or face tariffs up t

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at e

On July 2, 2026, International Medication Systems, Limited ("IMS"), a subsidiary of the Comp

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 poi

Top Wall Street analysts changed outlook on top stocks. See all changes including upgrades, downgrad

B of A Securities analyst Jason Gerberry downgrades Amphastar Pharma (NASDAQ:AMPH) from Neutral t

ARR, AMTB and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on June 23rd, 2026.

Amphastar Pharmaceuticals NASDAQ: AMPH is positioning itself for a broader shift from complex generi

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar

Amphastar Pharmaceuticals NASDAQ: AMPH executives told investors at the Jefferies Healthcare Confere

Barclays analyst Glen Santangelo maintains Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight and

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH

Analysts downgraded DOCS, MWH, WHR, AMPH, and WIX and lowered price targets. See how analysts view t

Wells Fargo analyst Benjamin Burnett downgrades Amphastar Pharma (NASDAQ:AMPH) from Overweight to

Amphastar Pharmaceuticals NASDAQ: AMPH executives said the company is taking steps to address rebate

Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026

Piper Sandler analyst David Amsellem reiterates Amphastar Pharma (NASDAQ:AMPH) with a Neutral and

Wall Street analysts changed outlook on top names. Check all changes on analyst ratings page. See wh

Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript

Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the

Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.42 per share, missing the Za

Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 mil

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

RANCHO CUCAMONGA, CA / ACCESS Newswire / April 30, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AM

Investors interested in stocks from the Medical - Generic Drugs sector have probably already heard o

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quar

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo